CCL2 and congenital rubella syndrome: Myeloid-targeting with anti-hVISTA antibody JNJ induced the release of CRS-associated human cytokines, particularly monocytes/macrophages secreted and chemo-attractants’ chemokines such as CCL2, CCL5, and CXCL8.